Skip to main content

Find Clinical Trials

Home
Conditions
Muscular Dystrophies

Clinical trial condition

Muscular Dystrophies

Explore clinical trials studying Muscular Dystrophies. Study availability and eligibility vary by location and protocol.

61 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Muscular Dystrophies trial results

Completed

A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

NCT01254019

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations: GSK Investigational Site Buenos Aries, Buenos Aires, Argentina

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Curitiba, Paraná, Brazil

GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil

View all 47 locations

View Trial Details

Completed

Power Over Pain (POP) Study

NCT01800604

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Back Pain, +25 more
Locations: University of Washington, Ninth and Jefferson Building Seattle, Washington, United States

View Trial Details

Completed

Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies

NCT03317171

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscle Inflammation, +8 more
Locations: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Italy

View Trial Details

Completed

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

NCT01462292

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site Stanford, California, United States

GSK Investigational Site Gulf Breeze, Florida, United States

GSK Investigational Site Iowa City, Iowa, United States

View all 14 locations

View Trial Details

Completed

A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects

NCT01128855

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations: GSK Investigational Site Columbus, Ohio, United States

GSK Investigational Site Paris, France

View Trial Details

Completed

Quality of Life in Neuromuscular Disease

NCT02895763

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +6 more
Locations: Chu de Reims Reims, France

View Trial Details

Completed

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

NCT02432885

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)

NCT00027391

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscle Weakness, +11 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy

NCT00873782

Conditions: Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +11 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy

NCT01153932

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations: GSK Investigational Site Westmead, New South Wales, Australia

GSK Investigational Site Parkville, Victoria, Australia

GSK Investigational Site Ghent, Belgium

GSK Investigational Site Paris, France

View all 13 locations

View Trial Details